Literature DB >> 25998216

Objective measurement of high-level auditory cortical function in children.

Aseel Almeqbel1, Catherine McMahon2.   

Abstract

OBJECTIVE: This study examined whether the N2 latency of the cortical auditory evoked potential (CAEP) could be used as an objective indicator of temporal processing ability in normally hearing children.
METHODS: The N2 latency was evoked using three temporal processing paradigms: (1) differences in voice-onset-times (VOTs); (2) speech-in-noise using the CV/da/embedded in broadband noise (BBN) with varying signal-to-noise ratios (SNRs); and (3) 16Hz amplitude-modulated (AM) BBN presented (i) alone and (ii) following an unmodulated BBN, using four modulation depths. Thirty-four school-aged children with normal hearing, speech, language and reading were stratified into two groups: 5-7 years (n=13) and 8-12 years (n=21).
RESULTS: The N2 latency shifted significantly and systematically with differences in VOT and SNR, and was significantly different in the two AM-BBN conditions.
CONCLUSIONS: For children without an N1 peak in the cortical waveform, the N2 peak can be used as a sensitive measure of temporal processing for these stimuli. SIGNIFICANCE: N2 latency of the CAEP can be used as an objective measure of temporal processing ability in a paediatric population with temporal processing disorder who are difficult to assess via behavioural response.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Amplitude-modulated broadband noise (AM-BBN); Cortical auditory evoked potentials (CAEP); N2 latency; Speech-in-noise; Temporal processing; Voice-onset-time (VOT)

Mesh:

Year:  2015        PMID: 25998216     DOI: 10.1016/j.ijporl.2015.04.026

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  1 in total

1.  Evaluating long-latency auditory evoked potentials in the diagnosis of cortical hearing loss in children.

Authors:  Teresa Lopez-Soto; Amparo Postigo-Madueno; Pedro Nunez-Abades
Journal:  Oxf Med Case Reports       Date:  2016-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.